Wild mushrooms Clitocybe alexandri and Lepista inversa: In vitro antioxidant activity and growth inhibition of human tumour cell lines

Food and Chemical Toxicology

Volumn 48, Issue 10, 2010, Pages 2881-2884

  Vaz, Josiana A ^a,b   Heleno, Sandrina A ^a   Martins, Anabela ^a   Almeida, Gabriela M ^b   Vasconcelos, M Helena ^b   Ferreira, Isabel C F R ^a  

^a INSTITUTO POLITÉCNICO DE BRAGANÇA   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Antioxidant activity; Growth inhibitory activity; Wild mushrooms

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; CLITOCYBE ALEXANDRI EXTRACT; LEPISTA INVERSA EXTRACT; METHANOL; PHENOL; PLANT EXTRACT; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CANCER INHIBITION; CELL GROWTH; CLITOCYBE ALEXANDRI; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; LEPISTA INVERSA; LIPID PEROXIDATION; MUSHROOM; TUMOR CELL LINE; WILD SPECIES;

AGARICALES; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BETA CAROTENE; BIPHENYL COMPOUNDS; CELL LINE, TUMOR; CELL PROLIFERATION; FREE RADICAL SCAVENGERS; HUMANS; INDICATORS AND REAGENTS; PHENOLS; PICRATES; POLYSACCHARIDES; REDUCING AGENTS; REFERENCE STANDARDS;

BASIDIOMYCOTA; CLITOCYBE; LEPISTA;

EID: 77956392342     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.07.021     Document Type: Article

References (24)

1. Bezivin C., Lohezic F., Sauleau P., Amoros M., Boustie J. Cytotoxic activity of Tricholomatales determined with murine and human cancer cell lines. Pharm. Biol. 2002, 40:196-199.
2. Bon M. Guia de campo de los hongos de Europa 1988, Ediciones Omega, Barcelona.
3. Breitenbach J., Kränzlin F. Champignons de Suisse 2000, vols. 1-5. Mykologia Lucern, Lucern.
4. Cheng J.-J., Lin C.-Y., Lur H.-S., Chen H.-P., Lu M.-K. Properties and biological functions of polysaccharides and ethanolic extracts isolated from medicinal fungus, Formitopsis pinicola. Proc. Biochem. 2008, 43:829-834.
5. Courtecuisse R. Mushrooms of Britain and Europe 1999, HarperCollins Publishers, London.
6. Courtecuisse R., Duhem B. Guía de los hongos de la Península Ibérica, Europa y Norte de África 2005, Ediciones Omega, Barcelona.
7. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol. 2007, 18:581-592.
8. Ferreira I.C.F.R., Barros L., Abreu R.M.V. Antioxidants in wild mushrooms. Curr. Med. Chem. 2009, 16:1543-1560.
9. Finco F.D.B.A., Silva I.G., Ramos F. Antioxidant activity and native fruits from Brazilian Savannah. Free Rad. Res. 2009, 43:S27-97.
10. Fortin H., Tomasi S., Delcros J.-G., Bansard J.-Y., Boustie J. In vivo antitumor activity of Clitocine, an exocyclic amino nucleoside isolated from Lepista inversa. ChemMedChem 2006, 1:189-196.
11. Heleno S.A., Barros L., Sousa M.J., Martins A., Ferreira I.C.F.R. Study and characterization of selected nutrients in wild mushrooms from Portugal by gas chromatography and high performance liquid chromatography. Microchem. J. 2009, 93:195-199.
12. Heleno S.A., Barros L., Sousa M.J., Martins A., Ferreira I.C.F.R. Tocopherols composition of Portuguese wild mushrooms with antioxidant capacity. Food Chem. 2010, 119:1443-1450.
13. Karim-Kos H.E., Vries E., Soerjomataram I., Lemmens V., Siesling S., Coebergh J.W.W. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur. J. Cancer 2008, 44:1345-1389.
14. Larone D.H. Medically Important Fungi 2002, Amer Society for Microbiology, USA. fourth ed.
15. Lindequist U., Niedermeyer T.H.J., Julich W.-D. The pharmacological potential of mushrooms. eCAM 2005, 2:285-299.
16. Liu R.H. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J. Nutr. 2004, 134:3479S-3485S.
17. Marchand A. Champignons du Nord et du Midi 1986, vols.1-9. Société Mycologique des Pyrénées Méditerranéennes, Perpignan.
18. Mizuno T. Food function and medicinal effect of mushroom fungi. Foods Food Ingred. J. 1993, 158:55-70.
19. Monks A., Scudiero D., Skehan P., Shoemaker R., Paull K., Vistica D., Hose C., Langley J., Cronise P., Vaigro-Wolff A., Gray-Goodrich M., Campbell H., Mayo J., Boyd M. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Nat. Cancer Inst. 1991, 83:757-766.
20. Periasamy K., Natarajan K. Role of lignocellulosic enzymes during basidiomata production by Pleurotus djamor var. Roseus. Ind. J. Biotechnol. 2004, 3:577-583.
21. Pedro M.M., Cerqueira F., Sousa M.E., Nascimento M.S.J., Pinto M.M. Xanthones as inhibitors of growth of human cancer cell lines and their effects on the proliferation of human lymphocytes in vitro. Bioorg. Med. Chem. 2002, 10:3725-3730.
22. Skehan P., Storeng R., Scudiero D., Monks A., MacMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Nat. Cancer Inst. 1990, 82:1107-1112.
23. Zaidman B., Yassin M., Mahajana J., Wasser S.P. Medicinal mushrooms modulators of molecular targets as cancer therapeutics. Appl. Microbiol. Biotechnol. 2005, 67:453-468.
24. Zjawiony J.K. Biologically active compounds from Aphyllophorales (Polypore), Fungi. J. Nat. Prod. 2004, 67:300-310.